fda semaglutide shortage lawsuit faces new from compounders over wight loss drugs FDA declares semaglutide (Ozempic/Wegovy) shortage

With the right information, you can take confident steps toward better health

The differences and similarities between these drugs and all their brand names are legitimately confusing, said Stanford Medicine endocrinologist Sun Kim, MD

The biggest change I experienced at the start of taking Wegovy was a turning down of the food noise in my head

When administered as a once-weekly subcutaneous injection, tirzepatide binds to both GIP and GLP-1 receptors, triggering multiple metabolic effects throughout the body

Patients interested in GLP-1 therapy for fatty liver should discuss their individual circumstances with their GP or specialist, as eligibility depends on multiple factors including BMI, diabetes status, and cardiovascular risk profile